Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dabigatran trough levels in elderly patients pilot study
NL-OMON50084Phase 4Active, not recruiting
- Sponsor
- Catharina Ziekenhuis
- Start
- Aug 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of dabigatran in Atrial fibrillation (AFib), sponsored by Catharina Ziekenhuis. Primary endpoint: Dabigatran trough level. Started Aug 2017; status: active, not recruiting.
02
Drugs
dabigatran
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NL-OMON50084.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON50084.